Geagea Warns Against 'Implicating Lebanon in Adventures'

Lebanese Forces Leader Samir Geagea (Reuters)
Lebanese Forces Leader Samir Geagea (Reuters)
TT

Geagea Warns Against 'Implicating Lebanon in Adventures'

Lebanese Forces Leader Samir Geagea (Reuters)
Lebanese Forces Leader Samir Geagea (Reuters)

Lebanese Forces Party Leader Samir Geagea warned Hezbollah of engaging, alongside Iran, in any war that might break out in the region and considered such move as the “ruin of Lebanon.”

In an interview with Asharq Al-Awsat, Geagea noted that in the event of the eruption of a major Israeli-Iranian and US-Iranian confrontation, “which I believe is unlikely now”, Hezbollah “will think a lot” before engaging in it, “because it is not a simple thing and we should have a clear position taking into consideration the country’s interests.”

“No one should take part in any adventure because it is not the time for adventures. The region will be burning and we do not accept that anyone implicates the country and destroys it except in case of direct attack from any foreign country on Lebanon,” he stated.

On a different note, the LF leader said that the circumstances of the recent naturalization decree “constituted a blow to the tenure of President Michel Aoun,” ruling out, however, the president’s direct responsibility for the names included in the decree.

“Although it was the president who signed the decree, I believe that he was not informed of all the names included,” he said.

Geagea stressed that the problem with the current naturalization decree was that no one knew anything about it, which has raised many doubts.

“Everything was done secretly, away from politicians as well,” he said, adding: “Reactions among the Lebanese communities, whether among Shiite, Sunni, Christian or Druze, were negative, because those concerned behaved in a very suspicious manner, and therefore we couldn't remain silent on a subject like this, regardless of whether it was the best decree of the universe.”

On his assessment of the latest parliamentary elections, Geagea said his party fought the electoral battle alone, except in three districts where it allied with the Kataeb party.

He underlined in this regard that the Lebanese Forces’ electoral alliances were based on the party’s political stances, and were not mere alliances without any political meaning.

“We have fought the elections with new and acceptable figures, who reflect our reality and the image we would like to see in power and governance in Lebanon,” he noted.

As for the LF share in the next government, Geagea said his party must be represented based on its “popular, political and parliamentary size.”

“The elections proved that there are two great forces within the Christian community. They proved that there are equal forces,” he explained, noting that Christian representation in the government must be agreed upon by the LF and the Free Patriotic Movement (FPM) and the president.

Asked about his party’s relation with Foreign Minister Gebran Bassil, the LF leader emphasized that the real problem was not about governmental shares and ministerial portfolios, but about the principle of partnership.

“Bassil’s concept of partnership is to support anything that he does. As for us, partnership is when we agree and support each other in anything we want to do, and if no agreement is reached, we don’t support the step that we have not agreed upon,” he explained.

He noted in this regard that Bassil “considers himself to be representing the tenure”, but the LF always “avoids dragging the presidency into internal sensitivities.”

Geagea also said he believed that there were no obstacles hampering the formation of a new government.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.